Skip to content


Page 1 of 3

“It’s been known for decades that cancer cells use energy differently than most cell types,” said Harvard Stem Cell Institute's David Scadden. “So we thought, maybe there are metabolism differences between blood stem cells and their immediate descendants. And are they so different from cancer that you might be able to manipulate energy sources with something that could have an effect on cancer and not harm normal cells?”

Undermining leukemia

Harvard, MIT team finds that killing cancer cells by disrupting their metabolism doesn’t harm normal cells



A Harvard research team led by Kevin Kit Parker, a Harvard Stem Cell Institute principal faculty member, has identified a set of 64 crucial parameters by which to judge stem cell-derived cardiac myocytes, making it possible for scientists and pharmaceutical companies to quantitatively judge and compare the value of stem cells.

Quality control

Harvard researchers develop long-needed standards for gauging ‘good’ stem cells